focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
* arrive
** GAOTU
Forgive the sins of my keyboard!
🐸
When did the good new Preacher arrived in our house?
So full of compassion and something kind to say to all.
May the GOATU have mercy on us.
🐸
Lordloadsoflolly,
I can appreciate a good joke, but not when it's at the expense of others or discredits individuals like our CEO, Tim. As far as I'm aware, both Lisa and Tim are always available to discuss any concerns with serious investors. I have personally spoken with both of them. It's easy to hide behind a screen and make silly comments, but I invite you to actually call Tim if you've got the courage. You might be surprised to find he's more than willing to take your call and address any serious concerns you have directly. Let's keep the discourse respectful and constructive.
AlexanderUK - you DO realise it was a joke?
As, I presume, was your assertion about "the effort and openness he has consistently shown towards engaging with investors."
Lordloadsoflolly,
That's simply not true. Asserting that Tim's responses are pre-recorded undermines the effort and openness he has consistently shown towards engaging with investors. CEOs, especially of publicly traded companies, operate on tightly packed schedules. It's naive to expect Tim or any CEO to be immediately available for unscheduled calls. If you have genuine concerns or wish to discuss important matters further, demonstrate some initiative and arrange a meeting. Directly accusing or insinuating without taking constructive steps doesn't help anyone. If you're bold enough to make such claims here, I'd urge you to have the courage to address them directly with Tim. Let's see if your convictions hold up in a face-to-face discussion. Let us know how it goes!
Dallo
Thanks.
I am not sure that it does! I quoted from the RNS in August 2023 which seems to be contradicted by the later RNS.
Probably makes no difference-IMM should be able to get hold of the money needed if INC continues to power upwards.
Are any posters Scientists?
The spread is looking much better now, i would say primed to move up.
I will let you know if i het through
GoldGirl - that answerphone WAS actually Tim speaking to you.
It’s well known everything he says is pre-recorded.
Thanks Peter, will read in free time. At moment my focus is IMM. I gave Tim a callas wanted to discuss more but unfortunately went to answeing machine.
Hopefully he will call me back
Gla
Research OBI to be amazed by the potential
Client accounts with open positions in this market expect the price to rise
Hi Peter
I dont know much about obi but how do you think it compares with IMM. I noticed the obi mcap is twice that of imm.
Cheers
Wildbunch
Please read Business Update RNS of the 6th March 2024 where the company clearly states that the c7.3m warrants held by Immupharma in Incanthera are exercisable AT ANYTIME.
I trust this clarifies matters.
ATB
FTSE 350 when our drug for Lupus gets the go ahead and Incanth is flying high.
This is from the relevant RNS:
The Company entered into a Warrant Instrument ("Warrant Instrument") with Incanthera on 26 February 2020, whereby Incanthera created and issued Warrants to ImmuPharma to subscribe in cash at £0.095 per share, for 7,272,740 Ordinary Shares, valid until 6 September 2023.
· Incanthera has agreed with the Company to extend the Warrant Instrument by 12 months to 6 September 2024.
This does not suggest that the warrants can be exercised at any time-rather on or before 6 September this year.
Thank you
Mostly I am in OBI
but it has not ski-rocketed yet
Welcome Peter
So am in here
Nicely consolidating in the 2.5-2.6p range, form a stronger base for when we attack 3p. Dont forget 3p was paid yesterday.
Gla
Incanthera share price is now about 33% higher than early March
Where's Wally (aka Lambo222)?
And where's that placing he repeatedly said was imminent?
LifeOfPL
Thanks for posting all the assets and current state of play.
Hopefully market will realise this soon...
In December 2023, ImmuPharma highlighted that Incanthera plc ("Incanthera"), the dermatology and oncology specialist, had concluded a significant commercial skincare deal with Marionnaud (part of the A.S. Watson Group) initially across Europe and with further roll outs across Asia. It confirmed that this deal is expected to generate significant revenues and profitability for Incanthera, in 2024 and beyond.
Since then, Incanthera's share price has performed strongly.
ImmuPharma owns 9.9 million shares in Incanthera, representing a 10.8% holding with a value of £916k (as at close of business on 05 March). In addition, the Company also has 7.3 million warrants in Incanthera, which are exercisable at any time.
This represents a significant financial asset for ImmuPharma.
With progressive positive news flow expected from Incanthera during 2024, it would be anticipated this will have a significant positive impact on the value of the Company's underlying shareholding.